Zentalis Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.60

-0.10 (-3.70%)

As of Sep 28, 10:21 PM ET ·

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 10 63%

Hold 6 38%

Sell 0 0%

Price Target

Analyst Price Target +941.9% upside

Low Target $17.95

Average Target $27.09

High Target $27.14

Current Price $2.60

Current
$2.60

Target
$27.09

$17.95 $27.09 avg $27.14

Scenario Analysis

Bear Case

$17.95

590.4%

Low target

Base Case

$27.09

+941.9%

Avg target

Bull Case

$27.14

+943.8%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$6.95

-62.6% from high

52-Week Low

$1.21

+114.5% from low

Target vs 52W High

$27.09

+289.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%